These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16263895)

  • 1. Deactivating implantable cardioverter defibrillators.
    Ross HM
    Ann Intern Med; 2005 Nov; 143(9):690; author reply 691. PubMed ID: 16263895
    [No Abstract]   [Full Text] [Related]  

  • 2. Deactivating implantable cardioverter defibrillators.
    Lynn J
    Ann Intern Med; 2005 Nov; 143(9):691; author reply 691. PubMed ID: 16263897
    [No Abstract]   [Full Text] [Related]  

  • 3. Deactivating implantable cardioverter defibrillators.
    Beattie JM; Connolly MJ; Ellershaw JE
    Ann Intern Med; 2005 Nov; 143(9):690-1; author reply 691. PubMed ID: 16263894
    [No Abstract]   [Full Text] [Related]  

  • 4. The ethics of deactivating implanted cardioverter defibrillators.
    Berger JT
    Ann Intern Med; 2005 Apr; 142(8):631-4. PubMed ID: 15838070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
    Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
    Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
    Pilkington BC
    J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deactivation of advanced lifesaving technologies.
    Lipman HI
    Am J Geriatr Cardiol; 2007; 16(2):109-11. PubMed ID: 17342011
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.
    Morgenweck CJ
    Curr Opin Anaesthesiol; 2013 Apr; 26(2):171-5. PubMed ID: 23403711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicians' views regarding deactivation of cardiovascular implantable electronic devices in seriously ill patients.
    Mueller PS
    Heart Rhythm; 2010 Nov; 7(11):1543-4. PubMed ID: 20816871
    [No Abstract]   [Full Text] [Related]  

  • 10. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
    Kay GN; Bittner GT
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
    [No Abstract]   [Full Text] [Related]  

  • 11. [Deactivating pacemakers in terminally ill patients].
    Hotvedt R
    Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1680. PubMed ID: 18704136
    [No Abstract]   [Full Text] [Related]  

  • 12. Deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Mitchell SL; Brock DW
    Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
    Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
    Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Just Because We Can Doesn't Mean We Should": views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Ottenberg AL; Gerhardson S; Mueller LA; Kaufman SR; Koenig BA; Mueller PS
    J Interv Card Electrophysiol; 2011 Dec; 32(3):243-52. PubMed ID: 21805140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
    Zellner RA; Aulisio MP; Lewis WR
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
    [No Abstract]   [Full Text] [Related]  

  • 16. Deactivating cardioverter defibrillators near the end of life.
    BMJ; 2013 Jan; 346():f558. PubMed ID: 23364068
    [No Abstract]   [Full Text] [Related]  

  • 17. Pacemaker deactivation: withdrawal of support or active ending of life?
    Huddle TS; Amos Bailey F
    Theor Med Bioeth; 2012 Dec; 33(6):421-33. PubMed ID: 22351107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
    Gura MT
    AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.
    England R; England T; Coggon J
    J Med Ethics; 2007 Sep; 33(9):538-40. PubMed ID: 17761824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-of-kin responses and do-not-resuscitate implications for implantable cardioverter defibrillators.
    Morrison LJ; Sinclair CT
    Ann Intern Med; 2005 Apr; 142(8):676-7; author reply 677. PubMed ID: 15838078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.